Forbes January 13, 2024
It was my privilege to attend JP Morgan’s annual healthcare conference this week. I joined the three-day carousel of panel sessions, private meetings, press releases and networking events armed with five guiding questions about neurotechnology.
What will commercial success look like in 2024?
- Federal trust continues to grow: Neurotech companies doffed their caps to the FDA’s leadership across various centers, and commented on a welcome evolution from prior eras. In a track on business models, Christian Howell of Cognito Therapeutics spoke to numerous agencies’ willingness to work with companies early through a variety of programs (TCET, Breakthrough, NTAP, EPFP), as well as the overarching focus on relationship building, real world evidence, and continuous improvement.
- Business model innovation: On the...
Today's Sponsors
Today's Sponsor